ArticleClinical genitourinary cancer2020

The Efficacy of Lenvatinib Plus Everolimus in Patients with Metastatic Renal Cell Carcinoma Exhibiting Primary Resistance to Front-Line Targeted Therapy or Immunotherapy.

Lana Hamieh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.